PG
FBCG icon

Prostatis Group’s Fidelity Blue Chip Growth ETF FBCG Stock Holding History

Prostatis Group’s Portfolio FBCG Stock Details FBCG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$473K Buy
9,441
+2,094
+29% +$111K 0.12% 107
2025
Q4 		$403K Buy
7,347
+1,700
+30% +$92.2K 0.1% 115
2025
Q3 		$303K Buy
+5,647
New +$288K 0.08% 128

Other funds holding FBCG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DWM
Dynasty Wealth Management St. Petersburg, Florida $11.5B AUM 15.23% 1-Year Est. Return
SWP
Sagespring Wealth Partners Franklin, Tennessee $5.49B AUM 19.47% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Prostatis Group's FBCG Position: Q1 2026 in Review

Prostatis Group increased its Fidelity Blue Chip Growth ETF (FBCG) stake by 29% in Q1 2026, buying an estimated $111K and bringing the position to 9,441 shares worth $473K. The position accounts for 0.12% of the portfolio, ranked #107.

Prostatis Group first reported a position in FBCG in Q3 2025 and has held it in 3 quarters since. 265 funds tracked by Wall St. Rank hold FBCG as of Q1 2026.

  • Prostatis Group held 9,441 shares of Fidelity Blue Chip Growth ETF worth $473K as of Q1 2026.
  • Prostatis Group bought 2,094 Fidelity Blue Chip Growth ETF shares in Q1 2026, an estimated $111K.
  • Fidelity Blue Chip Growth ETF made up 0.12% of Prostatis Group's portfolio in Q1 2026, its #107 holding.
  • Prostatis Group first reported a position in Fidelity Blue Chip Growth ETF in Q3 2025 and has held it in 3 quarters since.
  • 265 funds tracked by Wall St. Rank held Fidelity Blue Chip Growth ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.